IDO1 and esophageal cancer: Similarly, augmented IDO expression in CAFs is observed in human esophageal cancers [99], and CAFs can also recruit and convert DCs into IDO-producing regulatory DCs [100], depleting tryptophan bioavailability, which consequently impedes effector T cell activation and proliferation [99,100].